Pretreatment of daily teriparatide enhances the increase of bone mineral density in cortical bones by denosumab therapy

BACKGROUND: While it is well known that teriparatide (TPTD) increases bone mineral density (BMD) in osteoporotic patients, it is unknown whether TPTD pretreatment affects BMD after denosumab (DMAb) therapy. METHODS: Fifty-seven patients in TPTD-pretreated group and 35 patients in DMAb-alone group ha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Clin Risk Manag
Main Authors: Kamimura, Mikio, Taguchi, Akira, Nakamura, Yukio, Koiwai, Hidefumi, Ikegami, Shota, Uchiyama, Shigeharu, Kato, Hiroyuki
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5892610/
https://ncbi.nlm.nih.gov/pubmed/29662314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S154686
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados